📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: BioMarin

1.1 - Company Overview

BioMarin Logo

BioMarin

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of innovative biopharmaceuticals for serious diseases and medical conditions, developing and commercializing them.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to BioMarin

Aeglea BioTherapeutics Logo

Aeglea BioTherapeutics

HQ: United States Website
  • Description: Provider of clinical-stage enzyme therapies for rare metabolic diseases and investigational monoclonal antibody programs for IBD, including SPY001 targeting α4β7 integrin and SPY002 targeting TL1A, with rational combination studies (SPY120, SPY130, SPY230) and precision immunology approaches using genetic or biomarker-based patient selection.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aeglea BioTherapeutics company profile →
Clementia Pharmaceuticals Logo

Clementia Pharmaceuticals

HQ: Canada Website
  • Description: Provider of clinical-stage, disease-modifying treatments for ultra-rare bone disorders and other debilitating diseases with high unmet medical need, including development of its lead product candidate, palovarotene, an oral small molecule.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Clementia Pharmaceuticals company profile →
Oxyrane Logo

Oxyrane

HQ: United Kingdom Website
  • Description: Provider of novel and biosuperior enzyme replacement therapies for lysosomal storage diseases. Pipeline includes OxyGCase for neuronopathic Gaucher disease and OXY2810 for Pompe disease. Offers the OxyCAT glycoengineered yeast-based platform to produce ERTs with enhanced cellular uptake and pharmacodynamics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oxyrane company profile →
Wilson Therapeutics Logo

Wilson Therapeutics

HQ: Sweden Website
  • Description: Provider of biopharmaceutical R&D focused on rare diseases, developing Decuprate as a new treatment for Wilson Disease, currently in a Phase II clinical study; based in Stockholm, Sweden.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Wilson Therapeutics company profile →
Aevi Genomic Medicine Logo

Aevi Genomic Medicine

HQ: United States Website
  • Description: Provider of research and development in genomic medicine focused on translating genetic discoveries into novel therapies, driven by a commitment to patients with pediatric onset life-altering diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aevi Genomic Medicine company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for BioMarin

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to BioMarin

2.2 - Growth funds investing in similar companies to BioMarin

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for BioMarin

4.2 - Public trading comparable groups for BioMarin

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to BioMarin

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About BioMarin

What does BioMarin do?

BioMarin is a provider of innovative biopharmaceuticals for serious diseases and medical conditions, developing and commercializing them.

Who are BioMarin's competitors?

BioMarin's competitors and similar companies include Aeglea BioTherapeutics, Clementia Pharmaceuticals, Oxyrane, Wilson Therapeutics, and Aevi Genomic Medicine.

Where is BioMarin headquartered?

BioMarin is headquartered in United States.

How many employees does BioMarin have?

BioMarin has 1,000 employees 🔒.

When was BioMarin founded?

BioMarin was founded in 2010 🔒.

What sector and industry vertical is BioMarin in?

BioMarin is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for BioMarin

Who are the top strategic acquirers in BioMarin's sector and industry

Top strategic M&A buyers and acquirers in BioMarin's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for BioMarin?

Top strategic M&A buyers groups and sectors for BioMarin include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in BioMarin's sector and industry vertical

Which are the top PE firms investing in BioMarin's sector and industry vertical?

Top PE firms investing in BioMarin's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in BioMarin's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in BioMarin's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in BioMarin's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to BioMarin include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in BioMarin's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for BioMarin?

The key public trading comparables and valuation benchmarks for BioMarin include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for BioMarin for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for BioMarin with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in BioMarin's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for BioMarin with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in BioMarin's' sector and industry vertical?

Access recent funding rounds and capital raises in BioMarin's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for BioMarin